Categories Analysis, Technology

Key takeaways from DocuSign’s (DOCU) Q4 2023 earnings report

In Q4, unadjusted profit benefited from higher interest income and income from other sources

DocuSign, Inc. (NASDAQ: DOCU), a leading provider of e-signature services, has been constantly increasing its market share by expanding the business into innovative areas like Contract Lifecycle Management. The digital signature market is estimated to grow to $48.4 billion by 2030 globally, representing a compound annual growth rate of 35.4%.

However, the macroeconomic challenges will be a hindrance to growth in the near term. Currently, DocuSign’s market capitalization is about $10.83 billion. The company’s top line grew by 14% to $659.6 million in the fourth quarter from $581 million a year earlier.  Earnings per share for the quarter was $0.02, compared to a loss of $0.15 per share in the year-ago fiscal quarter. Net income of $4.9 million benefited from higher interest income, and income from other sources. Adjusted EPS was $0.65, which is sharply higher than the $0.48 reported in the same period of the previous year.


Docusign Inc (DOCU) Q4 2023 Earnings Call Transcript


The contribution of Subscription revenue to the top line was 98% while Professional and Other revenues accounted for the remaining 2%. Fourth-quarter billings rose 10% to $739 million year-over-year. Together, cash, cash equivalents, restricted cash, and investments came in at $1.2 billion at the end of the quarter.

DocuSign Q4 2023 earnings infographic

In FY2023, the net loss widened to $0.49 per share on account of higher operating expenses – a 20% increase to 97.5 million. The management expects the current market headwinds to persist in the coming quarters. Adobe Inc. (NASDAQ: ADBE), DocuSign’s main rival that competes with the company for market share, will be reporting earnings this week.

Outlook

The management forecasts that total revenues would be between $639 million and $643 million in the first quarter of 2024 — subscription revenue in the range of $625 million to $629 million. Billings are expected to be in the range of $615 million to $625 million. For fiscal 2024, the company estimates revenue to be between $2.695 billion and $ 2.707 billion, while full-year billings are expected to be in the $2.705-$2.725 billion range.

What Next?

Though the stock created a big hype in the early phase of the pandemic lockdown – climbing to an all-time high in 2021 – it is currently trading a dismal 83% below that peak. There is a probability of further downfall this year if the financial performance is weak in the coming quarters.  

Last week, DOCU fell about 19% soon after the earnings release. At the moment, it is advisable to follow a watch-and-wait policy, for investing. However, the industry has upside potential, and it is likely to stabilize once the market gyrations get over in the next few months.

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top